Kazia Therapeutics-Spon ADRKZIA
13F holders, Q2 2024 (June 30)11holders
4new positions
4sold out
1famous investor
$0.23avg. 13F price*
At the end of Q2 2024, 11 institutions reported holding Kazia Therapeutics-Spon ADR (KZIA) in their 13F filings, unchanged from Q1 2024. 4 opened new positions and 4 sold out. The largest holders were Morgan Stanley ($46K), BNP Paribas Financial Markets ($15K) and Susquehanna International Group, LLP ($9K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Kazia Therapeutics-Spon ADR
- CUSIP
- 48669G105
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $25K |
| Exits | 4 | $35K |
All 13F filers, Q1 2024 → Q2 2024: 132,302 shares bought and 112,017 shares sold, net +20,285 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Morgan Stanley | 0.00% | Add +1.6% | 201,082 | $46K |
| BNP Paribas Financial Markets | 0.00% | Add +30.8% | 63,568 | $15K |
| Susquehanna International Group, LLP | 0.00% | New | 41,478 | $9K |
| Virtu Financial LLC | 0.00% | New | 39,277 | $9K |
| UBS Group AG | 0.00% | New | 23,336 | $5K |
| Rhumbline Advisers | 0.00% | Add +44.7% | 17,615 | $4K |
| Citadel Advisors | 0.00% | New | 4,566 | $1K |
| Wells Fargo & Company | 0.00% | No change | 500 | $114 |
| Allworth Financial LP | 0.00% | No change | 87 | $46 |
| JPMorgan Chase & Co. | 0.00% | No change | 3 | $1 |
| AdvisorNet Financial, Inc | 0.00% | No change | 5 | $1 |
"% of holder's portfolio" is KZIA's weight in each manager's 13F, not the share of Kazia Therapeutics-Spon ADR the manager owns.